Company intelligence / Profile preview

Florica Therapeutics

Livermore, California, United Statesfloricatherapeutics.com ↗

Ownership: Private
Employees: ~3
Development stage: Preclinical

Overview

Florica Therapeutics is developing a novel exosome-based platform using human hypothalamus stem cell-derived exosomes to deliver gene therapies and biologic drugs across the blood-brain barrier. Their lead indication is rare pediatric neurological disease, specifically Tay-Sachs Disease. The company has received competitive non-dilutive funding, including a National Science Foundation SBIR Phase 1 grant in 2021 to study brain/immune interactions in COVID and lay groundwork for their therapeutic approach. No clinical trial results have been reported as of May 2025; programs are preclinical.

Therapeutic areas: OtherImmunologyNeurology
Modalities: Exosome-based therapeuticsGene therapy productsRegenerative medicine from human hypothalamus stem cells
Industry: Biotech

Drug pipeline

1 asset

Hypothalamus stem cell exosomes

Pre-clinical

Indications: Tay-Sachs Disease, COVID-19

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed as of May 2025.

Beyond the preview

Go deeper on Florica Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Florica Therapeutics.

Explore the full profile